Chartier-Kastler E - Search Results

1

The effects of focused extracorporeal pyrotherapy on a human bladder tumor cell line (647 V).

Chartier-Kastler E, Chopin D, Vallancien G. Chartier-Kastler E, et al. J Urol. 1993 Mar;149(3):643-7. doi: 10.1016/s0022-5347(17)36171-2. J Urol. 1993. PMID: 8437282

2

Association between frailty and detrusor overactivity with detrusor underactivity in older women.

Ly OD, Monaghan TF, Chartier-Kastler E, Petrovic M, Goessaert AS, Everaert K, Robain G, Haddad R; NOPIA Research Group. Ly OD, et al. Neurourol Urodyn. 2024 Jun;43(5):1075-1082. doi: 10.1002/nau.25381. Epub 2024 Jan 30. Neurourol Urodyn. 2024. PMID: 38289326 Review.

3

Focussed extracorporeal pyrotherapy: experimental results.

Vallancien G, Chartier-Kastler E, Chopin D, Veillon B, Brisset JM, André-Bougaran J. Vallancien G, et al. Eur Urol. 1991;20(3):211-9. doi: 10.1159/000471702. Eur Urol. 1991. PMID: 1726638

4

Focused extracorporeal pyrotherapy: experimental study and feasibility in man.

Vallancien G, Chartier-Kastler E, Harouni M, Chopin D, Bougaran J. Vallancien G, et al. Semin Urol. 1993 Feb;11(1):7-9. Semin Urol. 1993. PMID: 7682004 No abstract available.

5

Focused extracorporeal pyrotherapy.

Vallancien G, Chartier-Kastler E, Bataille N, Chopin D, Harouni M, Bougaran J. Vallancien G, et al. Eur Urol. 1993;23 Suppl 1:48-52. doi: 10.1159/000474680. Eur Urol. 1993. PMID: 7685697 Clinical Trial.

6

[Prospective, multicentric, open, and controlled evaluation of the effectiveness of prostatron 2.5 in the treatment of prostatic benign hypertrophy: 1-year results].

Gattegno B, Ciofu C, Flahaut A, Chartier-Kastler E, Desgrandchamps F, Martin X, Vallancien G, Teillac P, Richard F. Gattegno B, et al. Prog Urol. 2000 Dec;10(6):1184-9. Prog Urol. 2000. PMID: 11217557 Clinical Trial. French.

7

Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.

Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O. Rouprêt M, et al. Urology. 2006 Jun;67(6):1181-7. doi: 10.1016/j.urology.2005.12.034. Urology. 2006. PMID: 16765178

8

Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.

Peycelon M, Hupertan V, Comperat E, Renard-Penna R, Vaessen C, Conort P, Bitker MO, Chartier-Kastler E, Richard F, Rouprêt M. Peycelon M, et al. J Urol. 2009 Jan;181(1):35-41. doi: 10.1016/j.juro.2008.09.025. Epub 2008 Nov 13. J Urol. 2009. PMID: 19012929

9

Analysis of bladder cancer subtypes in neurogenic bladder tumors.

Manach Q, Cussenot O, Rouprêt M, Gamé X, Chartier-Kastler E, Reus C, Camparo P, Compérat E, Phé V. Manach Q, et al. Can J Urol. 2018 Feb;25(1):9161-9167. Can J Urol. 2018. PMID: 29524970

10

Malignancy after Augmentation Enterocystoplasty: A Nationwide Study of Natural History, Prognosis and Oncogene Panel Analysis.

Garnier S, Vendrell J, Boillot B, Karsenty G, Faure A, Blanc T, Soustelle L, Phe V, Even A, Chartier-Kastler E, Ravasse P, Poinas G, Leizour B, Costa P, Galmiche L, Iborra F, Bouali O, Game X, Solassol J, Kalfa N. Garnier S, et al. J Urol. 2020 Jul;204(1):136-143. doi: 10.1097/JU.0000000000000752. Epub 2020 Jan 20. J Urol. 2020. PMID: 31957550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters